Literature DB >> 28108249

Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors.

Chao Chen1, Jiemei Song1, Jinzheng Wang1, Chang Xu1, Caiping Chen1, Wei Gu2, Hongbin Sun3, Xiaoan Wen4.   

Abstract

Herpesvirus-associated Ubiquitin-Specific Protease (HAUSP, also called USP7) interacts with and stabilizes Mdm2, and represents one of the first examples that deubiquitinases oncogenic proteins. USP7 has been regarded as a potential drug target for cancer therapy. Inhibitors of USP7 have been recently shown to suppress tumor cell growth in vitro and in vivo. Based on leading USP7 inhibitors P5091 and P22077, we designed and synthesized a series of thiazole derivatives. The results of in vitro assays showed that the thiazole compounds exhibited low micromolar inhibition activity against both USP7 enzyme and cancer cell lines. The compounds induced cell death in a p53-dependent and p53-independent manner. Taken together, this study may provide thiazole compounds as a new class of USP7 inhibitors.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Human colon cancer; Thiazole derivatives; USP7 inhibitor

Mesh:

Substances:

Year:  2017        PMID: 28108249     DOI: 10.1016/j.bmcl.2017.01.018

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

Review 1.  Deubiquitinases: Pro-oncogenic Activity and Therapeutic Targeting in Blood Malignancies.

Authors:  Blanca T Gutierrez-Diaz; Wei Gu; Panagiotis Ntziachristos
Journal:  Trends Immunol       Date:  2020-03-02       Impact factor: 16.687

2.  Discovery and characterization of highly potent and selective allosteric USP7 inhibitors.

Authors:  Gerald Gavory; Colin R O'Dowd; Matthew D Helm; Jakub Flasz; Elias Arkoudis; Anthony Dossang; Caroline Hughes; Eamon Cassidy; Keeva McClelland; Ewa Odrzywol; Natalie Page; Oliver Barker; Hugues Miel; Timothy Harrison
Journal:  Nat Chem Biol       Date:  2017-12-04       Impact factor: 15.040

Review 3.  Modulating protein-protein interaction networks in protein homeostasis.

Authors:  Mengqi Zhong; Gregory M Lee; Eline Sijbesma; Christian Ottmann; Michelle R Arkin
Journal:  Curr Opin Chem Biol       Date:  2019-03-23       Impact factor: 8.822

4.  Targeting HAUSP in both p53 wildtype and p53-mutant tumors.

Authors:  Omid Tavana; Hongbin Sun; Wei Gu
Journal:  Cell Cycle       Date:  2018-05-15       Impact factor: 4.534

5.  Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7.

Authors:  Ilaria Lamberto; Xiaoxi Liu; Hyuk-Soo Seo; Nathan J Schauer; Roxana E Iacob; Wanyi Hu; Deepika Das; Tatiana Mikhailova; Ellen L Weisberg; John R Engen; Kenneth C Anderson; Dharminder Chauhan; Sirano Dhe-Paganon; Sara J Buhrlage
Journal:  Cell Chem Biol       Date:  2017-10-19       Impact factor: 8.116

Review 6.  Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease.

Authors:  Radhika Rawat; Daniel T Starczynowski; Panagiotis Ntziachristos
Journal:  Curr Opin Cell Biol       Date:  2019-03-18       Impact factor: 8.382

7.  p53 modifications: exquisite decorations of the powerful guardian.

Authors:  Yanqing Liu; Omid Tavana; Wei Gu
Journal:  J Mol Cell Biol       Date:  2019-07-19       Impact factor: 6.216

Review 8.  Targeting Ubiquitin-Specific Protease 7 (USP7) in Cancer: A New Insight to Overcome Drug Resistance.

Authors:  Jiabin Lu; He Zhao; Caini Yu; Yuanyuan Kang; Xiaochun Yang
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 9.  DUBs Activating the Hedgehog Signaling Pathway: A Promising Therapeutic Target in Cancer.

Authors:  Francesca Bufalieri; Ludovica Lospinoso Severini; Miriam Caimano; Paola Infante; Lucia Di Marcotullio
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.639

Review 10.  Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?

Authors:  Si-Min Qi; Gang Cheng; Xiang-Dong Cheng; Zhiyuan Xu; Beihua Xu; Wei-Dong Zhang; Jiang-Jiang Qin
Journal:  Front Cell Dev Biol       Date:  2020-04-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.